SF 131

  • Minnesota Senate Bill
  • 2021-2022 Regular Session
  • Introduced in Senate Jan 14, 2021
  • Senate
  • House
  • Governor

Drug manufacturers requirement to report and maintain prescription drug prices authorization; prescription drug formularies filing requirement; health carriers denying or limiting coverage due to lack of prior authorization prohibition; prescription benefit tool requirements establishment; prescription drug benefit transparency and disclosure requirement

Votes


No votes to display

Actions


Mar 28, 2022

Senate

Author added Nelson

Mar 09, 2022

Senate

Author added Putnam

Jan 14, 2021

Senate

Introduction and first reading

Senate

Referred to Health and Human Services Finance and Policy

Bill Text

Bill Text Versions Format
Introduction APPLCATION/PDF HTML

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Minnesota Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.